海峡药学2024,Vol.36Issue(8) :73-77.

HPLC-MS/MS法同时测定人血浆中对乙酰氨基酚和布洛芬

Simultaneous Determination of Acetaminophen and Ibuprofen in Human Plasma by HPLC-MS/MS

马彦博 王美银 彭路路 张枢 李小川 段小群
海峡药学2024,Vol.36Issue(8) :73-77.

HPLC-MS/MS法同时测定人血浆中对乙酰氨基酚和布洛芬

Simultaneous Determination of Acetaminophen and Ibuprofen in Human Plasma by HPLC-MS/MS

马彦博 1王美银 2彭路路 2张枢 2李小川 1段小群3
扫码查看

作者信息

  • 1. 桂林医学院药学院,广西桂林 541100;苏州旭辉检测有限公司,江苏苏州 215300
  • 2. 苏州旭辉检测有限公司,江苏苏州 215300
  • 3. 桂林医学院药学院,广西桂林 541100
  • 折叠

摘要

目的 建立一种可以同时测定人血浆中对乙酰氨基酚和布洛芬的液相色谱-串联质谱法(HPLC-MS/MS).方法 选用对乙酰氨基酚-d3和布洛芬-d3为内标,采用甲醇蛋白沉淀法处理血浆样品.色谱柱采用ZORBAX Extend C18(4.6 × 150 mm,3.5 μm),选用梯度洗脱方式,流动相A为5 mM乙酸铵水溶液,流动相B为甲醇;采用电喷雾离子化多反应监测模式:0~3.50 min,以正离子检测对乙酰氨基酚和对乙酰氨基酚-d3,3.5~5.5 min,以负离子检测布洛芬和布洛芬-d3.结果 对乙酰氨基酚和布洛芬分别在0.0400-10.0 μg·mL-1、0.100~25.0 µg·mL-1内线性关系良好,且精密度、回收率、稳定性等考察均符合要求.结论 该方法快速简便,灵敏、准确且选择性好,适用于对乙酰氨基酚和布洛芬的临床药代动力学研究.

Abstract

OBJECTIVE To develop a high performance liquid chromatography-tandem mass spectrometry(HPLC-MS/MS)for simultaneous determination of acetaminophen and ibuprofen in human plasma.METHODS Plasma samples were treated by the protein precipitation method with methanol and the internal standard was acet-aminophen-d3 and ibuprofen-d3.A ZORBAX Extend C18(4.6 × 150 mm,3.5 µm)column was used for gradient elu-tion with 5 mM ammonium acetate aqueous solution as mobile phase A and methanol as mobile phase B.Electrospray ionization multi-reaction monitoring mode was used:0-3.50 min,positive ions were used to detect acetaminophen and acetaminophen-d3,3.5-5.5 min,negative ions were used to detect ibuprofen and ibuprofen-d3.RESULTS The calibration curves of acetaminophen and ibuprofen were linear in the ranges of 0.0400-10.0 μg·mL-1 and 0.100-25.0 µg·mL-1,and the precision,recovery and stability investigation conforms to the require-ments.CONCLUSION The method is rapid,simple,sensitive,precise and selective.It is suitable for the study of clinical pharmacokinetics of acetaminophen and ibuprofen.

关键词

HPLC-MS/MS/对乙酰氨基酚/布洛芬/药动学

Key words

HPLC-MS/MS/Acetaminophen/Ibuprofen/Pharmacokinetics

引用本文复制引用

基金项目

&&(桂科AA22096025)

出版年

2024
海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
段落导航相关论文